Intralesional Cidofovir and Surgical Excision for Laryngeal Papillomatosis

Laryngoscope

Volumn 113, Issue 12, 2003, Pages 2174-2181

  Naiman, Ana Nusa ^a   Ceruse, Philip ^a   Coulombeau, Bruno ^a   Froehlich, Patrick ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Cidofovir; Endoscopy; Larynx; Papillomatosis; Surgical excision

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR;

ADOLESCENT; ADULT; ARTICLE; CARBON DIOXIDE LASER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE; KIDNEY FAILURE; LARYNGOSCOPY; LARYNX DISORDER; LARYNX PAPILLOMATOSIS; MALE; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; PROTEINURIA; RETINITIS; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTOSINE; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LARYNGEAL NEOPLASMS; LARYNGOSCOPY; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMA; PHOSPHONIC ACIDS; TREATMENT OUTCOME;

EID: 0347951340     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200312000-00024     Document Type: Article

References (15)

1. Myer CM, Wiliging P, Cotton R. Use of a laryngeal microresector system. Laryngoscope 1999;109:1165-1166.
2. Bower CM, Wanes M, Flock S, Schaeffer R. Flash pump dye laser treatment of laryngeal papillomatosis. J Voice 1999;13:123-127.
3. McMillan K, Shapshay SM, McGilligan JA, et al. A 585 nm meter pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope 1998;108:968-972.
4. De Clercq E. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh K Acad Geneesk Belg 1996;58:19-47.
5. Andrei G, Snoeck R, Piette J, et al. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol Res 1998;10:523-531.
6. Snoeck R, Andrei G, De Clercq E. Cidofovir in the treatment of HPV associated lesions. Verh K Acad Geneeskd Belg 2001;63:93-120, discussion 120-122.
7. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of Cidofovir [(S)-1-(3-Hydroxy-2-(Phosphonylmetoxypropyl) Cytosine]. J Med Virol 1998;54:219-225.
8. Pransky SM, Magit AE, Kearns DB, et al. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 1999;125:1143-1148.
9. Van Custem E, Snoeck R, Van Ranst M, et al. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of 1-(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J Med Virol 1995;45:230-235.
10. Pransky SM, Brewster DF, Magit AE, Kearns DB. Clinical update on 10 children treated with intralesional cidofovir injections. Arch Otolaryngol Head Neck Surg 2000;126:1239-1243.
11. Wilson WR, Hashemiyoon R, Hawrych A. Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report. Ear Nose Throat J 2000;79:236-240.
12. Bielamowicz S, Villagomez V, Stager SV, Wilson WR. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 2002;112:696-699.
13. Derkay CS, Malis DJ, Zalzal G, et al. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998;108:935-937.
14. Ho HT, Woods KL, Bronson JJ, et al. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmetoxy)propyl]cytosine. Mol Pharmacol 1992;41:197-202.
15. Hoffman VF, Skiest DJ. Therapeutic developments in cytomegalovirus retinitis. Expert Opin Invest Drugs 2000;9:207-220.